KeyBanc initiated Olin Corp coverage with an Overweight rating and $26 price target, highlighting $1.5 billion in potential synergies from its merger with Huntsman Corp despite recent financial disapp
Olin Corporation's stock fell to a 52-week low of $17.02 after disappointing Q2 2026 earnings driven by volatile chemical markets and an unplanned plant outage, prompting analyst downgrades.
Olin Corporation's stock dropped to a 52-week low of $17.72 amid volatile chemical markets, plant outages, and litigation costs, despite maintaining 53 years of dividend payments.
Olin Corporation faces a securities fraud probe following an unplanned shutdown at its Texas vinyl chloride monomer plant. The incident is projected to reduce Q2 adjusted EBITDA by $40 million, causin
Pomerantz LLP is investigating Olin Corporation after an unplanned vinyl chloride monomer plant shutdown caused a $40 million EBITDA hit and a 16.51% stock price decline.
Olin Corporation updated its merger proxy disclosures with Huntsman following shareholder complaints about alleged omissions. The board maintains its recommendation for the deal despite disputing the
Olin Corporation is under investigation for potential securities fraud following an unplanned shutdown of its Texas vinyl chloride monomer plant. The incident reduced Q2 adjusted EBITDA by $40 million
Wall Street Zen downgraded Olin Corporation to a strong sell rating due to a negative outlook, though institutional investors hold significant shares. Analyst consensus remains Reduce with an average
Wells Fargo downgraded Olin Corporation to Equal Weight and lowered its price target to $20, citing weaker caustic soda pricing that compressed profit margins.
Truist Securities cut Olin's price target to $20 due to unplanned outage costs affecting 2026 results. The stock trades near its 52-week low after reporting wider-than-expected losses.
RBC Capital lowered Olin Corporation's stock price target to $20 citing weaker third-quarter guidance, following a 15.4% plunge after missed earnings estimates.
Olin Corporation reported Q2 2026 revenue of $1741.9M with a net loss, citing Chlor Alkali disruptions despite growth in Epoxy and Winchester segments. The company also announced an all-stock merger w
Olin Corp reported mixed Q2 results impacted by a $40 million VCM plant shutdown and litigation costs. The company proceeds with its transformative merger with Huntsman, targeting $400 million in syne
Olin Corporation missed Q2 2026 profit and sales estimates, causing its stock to drop 17%. The company attributed the loss to volatile chemical markets and an unplanned plant outage, while highlightin
Olin Corporation shares dropped to a 52-week low following disappointing Q2 results and an unplanned plant outage driven by volatile chemical markets.
Olin Corporation presents detailed quarterly and annual income statement data, including revenue, operating expenses, net income, and earnings per share. An FAQ section assists users in interpreting t
Olin Corp shares rose 4.7% to $24.24, yet GuruFocus rates the stock as 47.4% undervalued with a GF Score of 61/100 despite weak financial strength.
Analysts updated ratings for Olin Corporation and WD-40 Company in the Materials sector. Goldman Sachs maintains a Hold on Olin with a $24 target, while William Blair reiterates a Buy on WD-40.
Olin Corporation received SEC acceptance for its S-4 form regarding a business combination registration on July 14, 2026.
Olin Corporation (OLN) stock performance and fundamentals are analyzed, covering market cap, P/E ratios, and dividends. The report details ownership structures, volatility, and analyst recommendations
Olin Corporation announced its second quarter 2026 earnings conference call scheduled for July 31, 2026, at 9:00 a.m. ET. Senior management will review financial results released via press release aft
Olin Corp stock fell 3.2% to $24.93, trading significantly below its GF Value. However, low financial strength and a high P/E ratio suggest caution despite the apparent undervaluation.
Olin Corporation shares traded steadily on the NYSE alongside the broader US chemicals sector as investors anticipate upcoming earnings reports driven by chlor-alkali and epoxy market conditions. Reve
UBS raised Olin's price target to $31 after a Q1 earnings beat, updating EBITDA estimates due to higher pricing for caustic soda and epoxy.
A strike at Olin Corp.'s Winchester division has ended following a ratified agreement covering 1,300 workers. The company reported an $83 million Q1 2026 loss attributed to higher raw material costs d
Morgan Stanley maintained an Underweight rating on Olin Corporation while raising its price target to $22.00, citing cautious outlook despite potential undervaluation and moderate long-term growth pot
Olin Corporation posted a Q1 2026 net loss of $83 million amid declining sales and EBITDA, citing segment weakness and litigation costs. Net debt to adjusted EBITDA rose to 5.1 times.
Olin Corporation reported a first-quarter net loss of $83 million, though revenue of $1.58 billion exceeded Wall Street expectations. Adjusted earnings per share were 65 cents after restructuring cost
Olin Corporation director Edward Daly received 7,023 phantom stock units valued at $200,560 as part of his annual compensation package. These units convert to common stock on a one-to-one basis, incre
Olin Corporation director William H. Weideman was granted 7,023 phantom stock units as part of his annual compensation plan, bringing his total holdings to 53,657 units.
Olin Corp director Beverley A. Babcock received equity-based compensation including 2,107 common shares and 4,916 phantom stock units under the Non-Employee Director Deferred Compensation Plan.
Olin Corp VP Marc Ehrhardt converted 7,706 RSUs to common stock and withheld 1,877 shares for taxes. He now directly holds 25,206 shares with remaining RSUs pending vesting.
Olin Corporation shareholders approved the 2026 Long Term Incentive Plan and declared a quarterly dividend of $0.20 per share. The board amended bylaws to reduce director count and re-elected eight di
Olin Corporation faces an ongoing strike at its Lake City Army Ammunition Plant after the union rejected the latest contract offer. The dispute involves the International Association of Machinists and
Missouri lawmakers are pressuring Olin Corp to resume negotiations with over 1,300 striking ammunition plant workers before their health insurance expires.
Citi raised its price target for Olin Corporation to $30, citing positive commodity chemical previews. This follows similar upgrades by RBC Capital driven by anticipated earnings uplift from petchem p
Olin Corp shares fell 4.3% to $28.17, while GuruFocus estimates an undervaluation of 41.9% at $48.49, citing low financial strength and insider selling as risks.
Over 1,300 union workers at Olin Corporation's Lake City Army Ammunition Plant have struck, halting production of small-caliber bullets for the U.S. military due to contract disputes.
UBS Group raised its price target for Olin Corporation to $29.00 from $21.00 while maintaining a neutral rating, though analyst consensus remains at $25.00.
Approximately 1,350 workers at Olin Winchester's Lake City Army Ammunition Plant are striking over contract terms, threatening U.S. small-caliber ammunition production. The dispute raises national sec
Wells Fargo upgraded Olin Corporation to an Overweight rating, raising its price target by 40% to $35 per share. Analyst Michael Sison cited improving prospects for the chemical manufacturer despite m
Wells Fargo upgraded Olin to 'overweight' with a $35 price target, though analyst consensus remains mixed following Q4 earnings and recent insider selling.
Olin Corporation announced its Q1 2026 earnings conference call will take place on May 8, 2026, at 9:00 a.m. ET, following the release of financial results on May 7.
Olin Corporation announced it will release Q1 2026 financial results after market close on May 7, followed by an investor conference call on May 8 at 9:00 a.m. ET. Webcast replays will be available fo
Mizuho raised its price target for Olin Corporation to $26 from $24, maintaining a neutral rating. Analyst consensus remains at "Hold" with an average target of $23.87 amidst mixed market views.
Olin reduced its Q4 EBITDA guidance after the CEO cited falling chlorine demand late in the quarter.
ChemBrief